Teva Women's Health Inc. gains three years of OTC market exclusivity for Plan B One-Step with FDA’s April 30 approval of the firm’s proposal to make the product available to consumers 15 and older, in a qualified form of OTC sale.
Plan B One-Step (levonorgestrel 1.5 mg), the second generation of the original two-dose Plan B (levonorgestrel 0
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?